v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Product revenue $ 317 $ 56 $ 362 $ 113
Operating expenses:        
Cost of sales 302 13 335 25
Research and development 697 642 1,298 1,482
Sales and marketing 0 197 10 312
General and administrative 1,151 1,685 2,222 2,796
Total operating expenses 2,150 2,537 3,865 4,615
Operating loss (1,833) (2,481) (3,503) (4,502)
Other income (expense), net:        
Interest income 7 0 20 0
Interest expense (3) (17) (5) (26)
Other income 6 0 6 0
Other income (expense), net 10 (17) 21 (26)
Net loss $ (1,823) $ (2,498) $ (3,482) $ (4,528)
Basic and diluted net loss per share (in dollars per share) $ (0.11) $ (0.18) $ (0.22) $ (0.32)
Weighted average common shares outstanding, basic and diluted (in shares) 15,918,979 14,258,511 15,918,979 14,102,918
Comprehensive loss:        
Net loss $ (1,823) $ (2,498) $ (3,482) $ (4,528)
Foreign currency translation adjustments (1) (21) (1) (22)
Comprehensive loss $ (1,824) $ (2,519) $ (3,483) $ (4,550)